Development and validation of a stability-indicating UPLC method for the determination of olmesartan medoxomil, amlodipine and hydrochlorothiazide degradation impurities in their triple-combination dosage form using factorial design of experiments.
UPLC
amlodipine besylate
degradation impurities
factorial design of experiments
hydrochlorothiazide
olmesartan medoxomil
Journal
Biomedical chromatography : BMC
ISSN: 1099-0801
Titre abrégé: Biomed Chromatogr
Pays: England
ID NLM: 8610241
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
revised:
13
05
2021
received:
04
04
2021
accepted:
07
06
2021
pubmed:
11
6
2021
medline:
27
1
2022
entrez:
10
6
2021
Statut:
ppublish
Résumé
The current work describes the development and validation of a stability-indicating UPLC method for the determination of olmesaratan medoxomil (OLM), amlodipine besylate (AMB), hydrochlorothiazide (HCT) and their degradation products in the triple-combination tablet dosage form. The separation was achieved using a Zorbax Eclipse plus C
Substances chimiques
Tablets
0
Hydrochlorothiazide
0J48LPH2TH
Amlodipine
1J444QC288
Olmesartan Medoxomil
6M97XTV3HD
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e5194Informations de copyright
© 2021 John Wiley & Sons, Ltd.
Références
Alexander, H. S., & Carsten, W. (2014). A QbD with design-of-experiments approach for development of a state-of-the-art UPLC purity method for carbamazepine. Journal of Liquid Chromatography and Related Technologies, 37(18), 2653-2666.
Ashok Kumar, J., Sathya, A., Senthil Kumar, K., Patil, S. N., Prathap, B., Lokesh, S. B., et al. (2010). Simultaneous estimation of olmesartan medoxomil and hydrochlorothiazide by RP-HPLC method from combined dosage forms. International Journal of Research in Pharmaceutical Sciences, 1(1), 24-27.
Bhavar, G. B., Chatpalliwar, V. A., Patil, D. D., & Surana, S. J. (2008). Validated HPTLC method for simultaneous determination of quinapril hydrochloride and hydrochlorothiazide in a tablet dosage form. Indian Journal of Pharmaceutical Sciences, 70(4), 529-531. https://doi.org/10.4103/0250-474X.44612
Bhusari, K. P., Khedekar, P. B., Dhole, S., & Banode, V. S. (2009). Derivative and Q-analysis spectrophotometric methods for estimation of hydrochlorothiazide and olmesartan medoxomil in tablets. Indian Journal of Pharmaceutical Sciences, 71(5), 505.
Blessy, M. R. D. P., Patel, R. D., Prajapati, P. N., & Agrawal, Y. K. (2013). Development of forced degradation and stability indicating studies of drugs-A review. Journal of Pharmaceutical Analysis, 4(3), 159-165. https://doi.org/10.1016/j.jpha.2013.09.003
Chitlange, S. S., Bagri, K., & Sakarkar, D. M. (2008). Stability indicating RPHPLC method for simultaneous estimation of valsartan and amlodipine in capsule formulation. Asian Journal of Research in Chemistry, 1(1), 15-18.
Daniels, S. L., & Vandervielen, A. J. (2006). Stability-indicating assay for hydrochlorothiazide. Journal of Pharmaceutical Sciences, 70(2), 211-215.
Desai, P. R., Mehta, P. J., & Chokshi, A. B. (2019). Stability indicating RP-HPLC method development and validation for simultaneous quantification of 15 organic impurities of olmesartan medoxomil, amlodipine and hydrochlorothiazide in combined dosage form. Chromatographia, 82, 819-833. https://doi.org/10.1007/s10337-019-03718-9
Dongala, T., Katakam, L. N. R., Palakurthi, A. K., & Katari, N. K. (2019). RP-HPLC stability indicating method development and validation of pseudoephedrine sulfate and related organic impurities in tablet dosage forms, robustness by QbD approach. Analytical Chemistry Letters, 9(5), 697-710.
Dongala, T., Palakurthi, A. K., Vytla, Y., & Katari, N. K. (2019). A novel UPLC-PDA isocratic method for the quantification fulvestrant in oil-based pre-filled syringe injection matrix formulations. Journal of Analytical Science and Technology, 10(12). https://doi.org/10.1186/s40543-019-0171-7
ICH. (2005). Q9 quality risk management. IFPMA. Geneva: International Conference on Harmonization. https://database.ich.org/sites/default/files/Q9%20Guideline.pdf
ICH. (2009). Q8 (R2) pharmaceutical development. IFPMA, Geneva: International Conference on Harmonization. https://database.ich.org/sites/default/files/Q8%28R2%29%20Guideline.pdf
Jain, P. S., Patel, M. K., Gorle, A. P., Chaudhari, A. J., & Surana, S. J. (2012). Stability-indicating method for simultaneous estimation of olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide by RP-HPLC in tablet dosage form. Journal of Chromatographic Science, 50(8), 680-687. https://doi.org/10.1093/chromsci/bms067
Jayaseelan, S., Rajasekar, M., Ganesh, S., Sekar, V., & Perumal, P. (2010). RP-HPLC method development and validation for simultaneous estimation of losartan potassium, amlodipine besilate and hydrochlorthiazide in tablet dosage form. Pharmaceutical Chemistry, 2(3), 31-36.
Kamblea, A. Y., Mahadika, M. V., Khatala, L. D., & Dhaneshwara, S. R. (2010). Validated HPLC and HPTLC method for simultaneous quantitation of amlodipine besylate and olmesartan medoxomil in bulk drug and formulation. Analytical Letters, 43, 251-258. https://doi.org/10.1080/00032710903325906
Katakam, L. N. R., & Dongala, T. (2020). Quality by design with design of experiments approach for the development of a stability-indicating LC method for benzonatate and its impurities in liquid oral dosage form. Separation Science Plus, 3(7), 276-285. https://doi.org/10.1002/sscp.202000023
Mali, A., & More, U. B. (2016). Development and validation of RP-HPLC method for simultaneous estimation of impurities from Olmesartan medoximil and hydrochlorothiazide tablet. International Journal of Pharmacy and Pharmaceutical Sciences, 8(5), 45-48.
Mehulkumar, P., Ramesh, V., Kumar, V. V., Srinivas, R., & Diwan, P. V. (2009). Simultaneous spectroscopic estimation of amlodipine besylate and olmesartan medoximil in tablet dosage form. Asian Journal of Research in Chemistry, 2(2), 127-130.
Merey, H. A., Ramadan, N. K., Diab, S. S., & Moustafa, A. A. (2014). Spectrophotometric methods for simultaneous determination of ternary mixture of amlodipine besylate, olmesartan medoxomil and hydrochlorothiazide. Spectrochimica Acta A, 125, 138-146. https://doi.org/10.1016/j.saa.2014.01.095
Ramadan, N. K., Mohamed, H. M., & Moustafa, A. A. (2010). Rapid and highly sensitive HPLC and TLC methods for quantitation of amlodipine besylate and valsartan in bulk powder and in pharmaceutical dosage forms and in human plasma. Analytical Letters, 43, 570-581. https://doi.org/10.1080/00032710903406953
Rao, J. R., Rajput, M. P., Yadav, S. S., Mulla, T. S., & Bharekar, V. V. (2011). Simultaneous quantitation of olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide in pharmaceutical dosage form by using HPLC. International Journal of PharmTech Research, 3(3), 1435-1440.
Rote, A. R., & Bari, P. D. (2010). Spectrophotometric estimation of olmesartan medoxomil and hydrochlorothiazide in tablet dosage form. Indian Journal of Pharmaceutical Sciences, 72(1), 111-113. https://doi.org/10.4103/0250-474X.62245
Safeer, K., Anbarasi, B., & Senthilkumar, N. (2010). Analytical method development and validation of amlodipine and hydrochlorothiazide in combined dosage form by RP-HPLC. International Journal of Chem Tech Research, 2(1), 21-25.
Shah, D. A., Bhatt, K. K., Mehta, R. S., Baldania, S. L., & Gandhi, T. R. (2008). Stability indicating RP-HPLC estimation of atorvastatin calcium and amlodipine besylate in pharmaceutical formulations. Indian Journal of Pharmaceutical Sciences, 70(6), 754-760. https://doi.org/10.4103/0250-474X.49117
Sharma, R. N., & Pancholi, S. S. (2009). Validated stability indicating LC-DAD method for determination of olmesartan medoxomil in tablets exposed to stress conditions. Acta Pharmaceutica Sciencia, 51, 323-331.
Solanki, T. B., Shah, P. A., & Patel, K. G. (2014). Central composite design for validation of HPTLC method for simultaneous estimation of olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide in tablets. Indian Journal of Pharmaceutical Sciences, 76(3), 179-187.
Subramanian, V. B., Katari, N. K., Dongala, T., & Jonnalagadda, S. B. (2020). Stability-indicating RP-HPLC method development and validation for determination of nine impurities in apixaban tablet dosage forms. Robustness study by quality by design approach. Biomedical Chromatography, 34(1), e4719.
Trabelsi, H., Hassen, I. E., Bouabdallah, S., Bouzouita, K., & Safta, F. (2005). Stability indicating LC method for the determination of pipamperone. Journal of Pharmaceutical and Biomedical Analysis, 39(5), 914-919. https://doi.org/10.1016/j.jpba.2005.05.031
US Food and Drug Administration. (2004). Guidance for industry PAT-A framework for innovative pharmaceutical development, manufacturing, and quality assurance. Pharmaceutical CGMPs: United states Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Vishnu, M. M., Krishnaiah, C., Srinivas, K., Srinivasa, R. K., Ramesh, K. N., & Mukkanti, K. (2013). Development and validation of RP-UPLC method for the determination of darifenacin hydrobromide, its related compounds and its degradation products using design of experiments. Journal of Pharmaceutical and Biomedical Analysis, 72, 40-50.
Younus, M., Reddy, T. K., Reddy, Y. R., & Arif, M. F. (2010). RP-HPLC method development and validation for simultaneous estimation of amlodipine besylate, valsartan and hydrochlorothiazide in tablet dosage form. Journal of Pharmaceutical Research, 3(11), 2647-2650.